Table 2 Bayesian multivariate expected length of stay (LOS) and readmission within 30 days showing median and 95% credible intervals for associations between asthma hospitalizations and significant risk factors (demographics, individual- comorbidities, temporal and place-based)

Age at visit by Sex

 Female

1.06 (1.03 to 1.08)

0.70 (0.67 to 0.73)

 Male

1.08 (1.04 to 1.12)

0.75 (0.70 to 0.80)

Race alone

 White EA

1 (Ref)

1 (Ref)

 Asian

1.0 (0.83 to 1.22)

1.0 (0.7 to 1.4)

 Black AA

0.80 (0.75 to 0.84)

1.12 (1.03 to 1.21)

 HL

0.73 (0.69 to 0.78)

1.02 (0.92 to 1.13)

 MENA

0.85 (0.61 to 1.15)

1.13 (0.68 to 1.82)

Insurance

 Private

1 (Ref)

1 (Ref)

 Public

1.14 (1.09 to 1.20)

1.39 (1.29 to 1.50)

Day of admission

 Weekday

1 (Ref)

1 (Ref)

 Weekend

0.88 (0.85 to 0.90)

1.10 (1.05 to 1.15)

Deprivation

–

1.0 (0.96 to 1.05)

Comorbidities

AR

 No

1 (Ref)

1 (Ref)

 Yes

0.77 (0.74 to 0.79)

0.96 (0.9 to 1.02)

Cancer

 No

1 (Ref)

1 (Ref)

 Yes

1.04 (1.0 to 1.07)

–

CHD

 No

1 (Ref)

1 (Ref)

 Yes

1.20 (1.16 to 1.25)

1.14 (1.07 to 1.22)

CKD

 No

1 (Ref)

1 (Ref)

 Yes

1.39 (1.32 to 1.45)

1.09 (1.01 to 1.18)

COPD

 No

1 (Ref)

1 (Ref)

 Yes

1.07 (1.03 to 1.10)

1.32 (1.24 to 1.40)

Depression

 No

1 (Ref)

1 (Ref)

 Yes

1.06 (1.02 to 1.09)

1.32 (1.25 to 1.40)

Diabetes

 No

1 (Ref)

1 (Ref)

 Yes

1.04 (1.0 to 1.08)

1.05 (0.99 to 1.12)

FA

 No

1 (Ref)

1 (Ref)

 Yes

–

1.08 (0.93 to 1.28)

GERD

 No

1 (Ref)

1 (Ref)

 Yes

1.03 (1.0 to 1.07)

1.21 (1.14 to 1.28)

HTA

 No

1 (Ref)

1 (Ref)

 Yes

1.07 (1.03 to 1.11)

1.28 (1.21 to 1.37)

Obesity

 No

1 (Ref)

1 (Ref)

 Yes

1.09 (1.05 to 1.13)

1.0 (0.94 to 1.06)

Psoriasis

 No

1 (Ref)

1 (Ref)

 Yes

–

1.16 (0.99 to 1.33)

Sleep apnea

 No

1 (Ref)

1 (Ref)

 Yes

1.06 (1.02 to 1.10)

1.01 (0.95 to 1.07)